Cardiff Oncology News

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Levine James E.

Mar 7 18:45 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kabbinavar Fairooz

Mar 7 18:40 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Smeal Tod

Mar 7 18:40 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Erlander Mark

Mar 7 18:40 ET

Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Acorn Bioventures, L.P.(4.20%),Acorn Capital Advisors GP, LLC(4.20%), etc.

Feb 6 16:03 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W

Dec 19, 2023 18:39 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W

Nov 14, 2023 16:24 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director Markin Rodney S

Jun 20, 2023 17:08 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director Armitage James O

Jun 20, 2023 17:06 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director White Lale

Jun 20, 2023 17:05 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W

Jun 20, 2023 17:04 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director Mohindru Mani

Jun 20, 2023 17:03 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P

Jun 20, 2023 17:02 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Smeal Tod

Mar 16, 2023 17:42 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Levine James E.

Mar 16, 2023 17:42 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kelemen Vicki

Mar 16, 2023 17:41 ET

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Erlander Mark

Mar 16, 2023 17:41 ET

Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caxton Corporation(2.2%),Bruce S. Kovner(2.2%), etc.

Feb 14, 2023 12:47 ET

Cardiff Oncology | 3: Initial statement of beneficial ownership of securities-Officer Kabbinavar Fairooz

Feb 9, 2023 16:50 ET

Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(0.0%)

Feb 9, 2023 09:23 ET